S&B Global Market Intelligence Quotes Arif Karim on Apple’s Chip Development Strategy
S&P Global Market Intelligence’s Agam Shah and Waqar Jamshed published an article discussing Apple’s semiconductor development strategy, which quotes Ensemble Capital’s Senior Investment Analyst Arif Karim.
As they note Apple has been targeted in the investments it has made in designing specific semiconductor components, bringing in house key pieces of technology development that have enabled it to differentiate the user experience of its hardware products such as the iPhone, iPad, and AirPods.
While the system processor and graphics processors have been long time in-house designed components, S&P Global discusses how important the modem chip is becoming, heretofore supplied by Qualcomm and Intel, especially ahead of the upcoming 5G launch and the applications it will allow.
This has become even more critical to Apple since the fight over license fees it pays to Qualcomm has cut off modem chip supply from the technology leader, while its current sole alternative, Intel, has continued to be late to market with competitive cutting-edge modem chips. The situation potentially handicaps the iPhone’s time to market on connective capabilities. Given the iPhone’s market position, customers generally expect it to have the advanced feature sets alternative smartphones using Qualcomm’s chips offer in their products when deciding to buy a new one.
For more information we recommend a read through of the linked S&P Global article, which provides great overview of Apple’s semiconductor development strategy.
While we do not accept public comments on this blog for compliance reasons, we encourage readers to contact us with their thoughts.
The information contained in this post represents Ensemble Capital Management’s general opinions and should not be construed as personalized or individualized investment, financial, tax, legal, or other advice. No advisor/client relationship is created by your access of this site. Past performance is no guarantee of future results. All investments in securities carry risks, including the risk of losing one’s entire investment. If a security discussed in this blog entry is owned by clients invested in Ensemble Capital’s core equity strategy you will find a disclosure regarding the security held above. If reviewing this blog entry after its original post date, please refer to our current 13F filing or contact us for a current or past copy of such filing. Each quarter we file a 13F report of holdings, which discloses all of our reportable client holdings. Ensemble Capital is a discretionary investment manager and does not make “recommendations” of securities. Nothing contained within this post (including any content we link to or other 3rd party content) constitutes a solicitation, recommendation, endorsement, or offer to buy or sell any securities or other financial instrument. Ensemble Capital employees and related persons may hold positions or other interests in the securities mentioned herein. Employees and related persons trade for their own accounts on the basis of their personal investment goals and financial circumstances.